Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

University of Arizona discloses compounds for Parkinson's disease

March 5, 2019

Principia Biopharma reports phase I data for PRN-2246

March 5, 2019

Optogenetics helps understand TDP-43 aggregates

March 5, 2019

Axsome initiates phase III trial of AXS-07 for acute treatment of migraine

March 4, 2019

Rodin Therapeutics identifies HDAC inhibitors

March 4, 2019

The Vanderbilt University discloses muscarinic M4 receptor antagonists

March 4, 2019

Single chain antibody against TDP-43 shows therapeutic potential in murine models of ALS/FTD

March 4, 2019

To sleep, perchance to clean: Sleep-inducing protein plays role in immunity

March 4, 2019

Minoryx receives Spanish clearance to begin phase II trial of MIN-102 in Friedreich's ataxia

March 1, 2019

Takeda Pharmaceutical presents the discovery of novel potent and selective Nav1.1 activator

March 1, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...